Liquidity ratios measure the company ability to meet its short-term obligations.
Paying user area
Try for free
Medtronic PLC pages available for free this week:
- Common-Size Income Statement
- Common-Size Balance Sheet: Assets
- Analysis of Profitability Ratios
- Analysis of Solvency Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Reportable Segments
- Price to FCFE (P/FCFE)
- Present Value of Free Cash Flow to Equity (FCFE)
- Selected Financial Data since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Medtronic PLC for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Liquidity Ratios (Summary)
Based on: 10-Q (reporting date: 2026-07-31), 10-K (reporting date: 2026-04-24), 10-Q (reporting date: 2026-01-23), 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30).
The liquidity profile demonstrates a period of volatility characterized by a significant contraction through mid-2022, followed by a phased recovery and subsequent stabilization. Overall, the entity maintains a liquidity position above the critical threshold of 1.0 for both the current and quick ratios, indicating a consistent capacity to meet short-term obligations.
- Current Ratio
- A marked decrease is observed from July 2021 (2.89) to a low of 1.58 in July 2022. This was followed by a recovery phase, peaking at 2.42 in July 2023 and reaching a subsequent high of 2.54 in January 2026. The ratio concluded the period at 2.07 in July 2026, suggesting a stable short-term solvency position despite periodic fluctuations.
- Quick Ratio
- The quick ratio mirrors the trajectory of the current ratio, falling from 2.06 in July 2021 to a minimum of 1.01 in July 2022. A recovery period followed, with the ratio reaching 1.55 in January 2026 before declining to 1.29 by July 2026. The parallel movement between the current and quick ratios indicates that inventory levels maintain a relatively consistent proportion of current assets.
- Cash Ratio
- The most conservative liquidity measure shows a decline from 1.36 in July 2021 to 0.63 in July 2022. For the remainder of the observed period, the ratio fluctuated within a range of 0.66 to 0.88, ending at 0.75 in July 2026. This indicates that while cash and cash equivalents are insufficient to cover all current liabilities independently, the cash position has remained relatively steady since the 2022 trough.
Current Ratio
| Jul 31, 2026 | Apr 24, 2026 | Jan 23, 2026 | Oct 24, 2025 | Jul 25, 2025 | Apr 25, 2025 | Jan 24, 2025 | Oct 25, 2024 | Jul 26, 2024 | Apr 26, 2024 | Jan 26, 2024 | Oct 27, 2023 | Jul 28, 2023 | Apr 28, 2023 | Jan 27, 2023 | Oct 28, 2022 | Jul 29, 2022 | Apr 29, 2022 | Jan 28, 2022 | Oct 29, 2021 | Jul 30, 2021 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
| Current assets | ||||||||||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||||||||||
| Liquidity Ratio | ||||||||||||||||||||||||||||
| Current ratio1 | ||||||||||||||||||||||||||||
| Benchmarks | ||||||||||||||||||||||||||||
| Current Ratio, Competitors2 | ||||||||||||||||||||||||||||
| Abbott Laboratories | ||||||||||||||||||||||||||||
| Elevance Health Inc. | ||||||||||||||||||||||||||||
| Intuitive Surgical Inc. | ||||||||||||||||||||||||||||
| UnitedHealth Group Inc. | ||||||||||||||||||||||||||||
Based on: 10-Q (reporting date: 2026-07-31), 10-K (reporting date: 2026-04-24), 10-Q (reporting date: 2026-01-23), 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30).
1 Q1 2027 Calculation
Current ratio = Current assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
The liquidity position of the entity exhibits significant volatility over the analyzed period, characterized by a sharp contraction in the current ratio during 2022 followed by a period of recovery and subsequent stabilization. While the current ratio remains above 1.0 throughout the entire timeframe, indicating a consistent ability to cover short-term obligations, the fluctuations suggest periodic shifts in short-term financing or working capital management.
- Current Ratio Fluctuations
- A marked decline in liquidity is observed from October 2021 to July 2022, where the current ratio fell from a peak of 2.91 to a low of 1.58. This trend reversed sharply between January 2023 and July 2023, with the ratio climbing back to 2.42. In the latter part of the sequence, the ratio transitioned into a more stable range, generally fluctuating between 1.84 and 2.54, ending at 2.07 in July 2026.
- Current Liabilities Dynamics
- The volatility in the current ratio is primarily attributed to significant swings in current liabilities rather than asset instability. Liabilities nearly doubled from $7.8 billion in October 2021 to a peak of $14.4 billion in January 2023. A substantial reduction occurred by April 2023, bringing liabilities down to approximately $9.0 billion. Subsequent periods show a fluctuating baseline between $9.4 billion and $12.8 billion.
- Current Assets Consistency
- Current assets remained relatively stable compared to liabilities, maintaining a range between $21.6 billion and $25.4 billion. The peak asset value of $25.4 billion was reached in October 2022, while the lowest point occurred in April 2023. This stability suggests that the changes in the liquidity ratio were driven by the timing and volume of short-term debt or accrued expenses rather than a depletion of liquid resources.
- Overall Liquidity Trend
- The long-term trend indicates a normalization of liquidity. After the volatility seen between 2021 and 2023, the entity established a sustainable current ratio typically exceeding 2.0. This suggests a conservative liquidity posture that provides a significant cushion against short-term financial obligations.
Quick Ratio
| Jul 31, 2026 | Apr 24, 2026 | Jan 23, 2026 | Oct 24, 2025 | Jul 25, 2025 | Apr 25, 2025 | Jan 24, 2025 | Oct 25, 2024 | Jul 26, 2024 | Apr 26, 2024 | Jan 26, 2024 | Oct 27, 2023 | Jul 28, 2023 | Apr 28, 2023 | Jan 27, 2023 | Oct 28, 2022 | Jul 29, 2022 | Apr 29, 2022 | Jan 28, 2022 | Oct 29, 2021 | Jul 30, 2021 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||||||||||
| Investments | ||||||||||||||||||||||||||||
| Accounts receivable, less allowances and credit losses | ||||||||||||||||||||||||||||
| Total quick assets | ||||||||||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||||||||||
| Liquidity Ratio | ||||||||||||||||||||||||||||
| Quick ratio1 | ||||||||||||||||||||||||||||
| Benchmarks | ||||||||||||||||||||||||||||
| Quick Ratio, Competitors2 | ||||||||||||||||||||||||||||
| Abbott Laboratories | ||||||||||||||||||||||||||||
| Elevance Health Inc. | ||||||||||||||||||||||||||||
| Intuitive Surgical Inc. | ||||||||||||||||||||||||||||
| UnitedHealth Group Inc. | ||||||||||||||||||||||||||||
Based on: 10-Q (reporting date: 2026-07-31), 10-K (reporting date: 2026-04-24), 10-Q (reporting date: 2026-01-23), 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30).
1 Q1 2027 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
The liquidity profile of the organization experienced significant volatility between July 2021 and July 2026, characterized by an initial sharp contraction followed by a period of stabilization. The quick ratio, which measures the ability to meet short-term obligations using the most liquid assets, began at a robust 2.06 and concluded the period at 1.29.
- Liquidity Contraction Phase (2021-2022)
- A marked decline in the quick ratio is observed from July 2021 to July 2022, where the ratio fell from 2.06 to its lowest point of 1.01. This deterioration was primarily driven by a substantial increase in current liabilities, which rose from 7,764 million to 14,049 million during this window, effectively offsetting the stability of total quick assets.
- Recovery and Rebound (2022-2023)
- A recovery phase occurred between July 2022 and April 2023, with the quick ratio climbing back to 1.54. This improvement is attributed to a significant reduction in current liabilities, which dropped to 9,051 million by April 2023, while quick assets remained relatively stable around 13,957 million.
- Stabilization and Fluctuating Equilibrium (2023-2026)
- From April 2023 through July 2026, the quick ratio entered a phase of fluctuating equilibrium, generally oscillating between 1.17 and 1.55. Total quick assets remained largely range-bound between 13.6 billion and 15.8 billion. Current liabilities showed periodic volatility, peaking at 12,879 million in January 2025 before moderating to 11,799 million by July 2026.
- Asset-to-Liability Correlation
- The data indicates that fluctuations in the quick ratio were more heavily influenced by changes in current liabilities than by variations in quick assets. The most significant shifts in liquidity occurred when liabilities expanded or contracted rapidly, while the asset base maintained a more consistent baseline throughout the five-year period.
Cash Ratio
| Jul 31, 2026 | Apr 24, 2026 | Jan 23, 2026 | Oct 24, 2025 | Jul 25, 2025 | Apr 25, 2025 | Jan 24, 2025 | Oct 25, 2024 | Jul 26, 2024 | Apr 26, 2024 | Jan 26, 2024 | Oct 27, 2023 | Jul 28, 2023 | Apr 28, 2023 | Jan 27, 2023 | Oct 28, 2022 | Jul 29, 2022 | Apr 29, 2022 | Jan 28, 2022 | Oct 29, 2021 | Jul 30, 2021 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||||||||||
| Investments | ||||||||||||||||||||||||||||
| Total cash assets | ||||||||||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||||||||||
| Liquidity Ratio | ||||||||||||||||||||||||||||
| Cash ratio1 | ||||||||||||||||||||||||||||
| Benchmarks | ||||||||||||||||||||||||||||
| Cash Ratio, Competitors2 | ||||||||||||||||||||||||||||
| Abbott Laboratories | ||||||||||||||||||||||||||||
| Elevance Health Inc. | ||||||||||||||||||||||||||||
| Intuitive Surgical Inc. | ||||||||||||||||||||||||||||
| UnitedHealth Group Inc. | ||||||||||||||||||||||||||||
Based on: 10-Q (reporting date: 2026-07-31), 10-K (reporting date: 2026-04-24), 10-Q (reporting date: 2026-01-23), 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30).
1 Q1 2027 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
The liquidity profile reflects a transition from a highly conservative cash position to a more lean operational structure. The cash ratio experienced a significant contraction between 2021 and 2022, subsequently stabilizing at a lower equilibrium throughout the remainder of the period.
- Cash Ratio Trends
- A period of high liquidity was observed from July 2021 through January 2022, with the ratio peaking at 1.37. A sharp decline followed, reaching a low of 0.63 in July 2022. Since that inflection point, the ratio has remained consistently below 1.0, fluctuating between a minimum of 0.66 and a maximum of 0.88, which indicates a strategic shift in how short-term obligations are covered by liquid assets.
- Total Cash Asset Movements
- Cash assets were maintained above the $10 billion threshold during the first three quarters of the analysis. A gradual decline began in 2022, leading to a period of lower cash reserves in 2023, where values dipped as low as $7.734 billion. Recent quarters demonstrate a stabilization phase, with cash assets generally oscillating between $7.8 billion and $9.2 billion.
- Current Liabilities Volatility
- A substantial increase in current liabilities is evident starting in April 2022, with obligations climbing from approximately $8.9 billion to a peak of $14.465 billion by October 2022. This surge in short-term liabilities was the primary driver of the cash ratio's decline. Following this peak, liabilities normalized and generally fluctuated between $9 billion and $12.8 billion.
- Overall Liquidity Interpretation
- The data suggests a movement away from maintaining a 1:1 cash-to-liability coverage. The convergence of the ratio toward the 0.75 to 0.85 range in the latter half of the period indicates a standardized approach to liquidity management, where the organization relies on a combination of cash and other current assets—or operational cash flow—to meet its immediate financial commitments.